- Home
- RGC vs PRVA Comparison
RGC vs PRVA Comparison
Compare RGC & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGC | PRVA |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RGC | PRVA |
|---|---|---|
| Price | $7.05 | $20.64 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $31.17 |
| AVG Volume (30 Days) | 149.4K | ★ 1.2M |
| Earning Date | 10-31-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.64 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $2,122,842,000.00 |
| Revenue This Year | N/A | $18.19 |
| Revenue Next Year | N/A | $10.72 |
| P/E Ratio | ★ N/A | $230.44 |
| Revenue Growth | N/A | ★ 22.26 |
| 52 Week Low | $4.51 | $19.53 |
| 52 Week High | $69.00 | $28.82 |
Technical Indicators
Market Signals| Indicator | RGC | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 60.05 | 30.32 |
| Support Level | $4.71 | $20.48 |
| Resistance Level | $6.75 | $25.04 |
| Average True Range (ATR) | 0.45 | 0.50 |
| MACD | 0.25 | 0.07 |
| Stochastic Oscillator | 85.56 | 23.63 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About PRVA Privia Health Group Inc.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.